Vestal Point Capital »

Liquidia Technologies shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Liquidia Technologies (LQDA) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Liquidia Technologies

Tip: Access up to 7 years of quarterly data

All positions including Liquidia Technologies held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liquidia Technologies by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 1.8M 12.00

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Liquidia Technologies

Caligan Partners
BlackRock
Vanguard Group
Findell Capital Management
State Street Corporation
Farallon Capital Management
Vestal Point Capital
Geode Capital Management
Susquehanna International
Kynam Capital Management
Whitefort Capital Management
Bank of America Corporation
Morgan Stanley
LMR Partners
Tang Capital Management

View all funds holding Liquidia Technologies